Journal d'oncologie orthopédique

Abstrait

Targeted Therapies for Soft Tissue Sarcoma: New Horizons in Treatment

Rhys Moorish*

Soft tissue sarcoma (STS) encompasses a diverse group of rare and challenging malignancies originating from soft tissues. Historically, treatment options have been limited to surgery, radiation, and chemotherapy, often yielding suboptimal outcomes. However, the emergence of targeted therapies has revolutionized the landscape of STS treatment, offering new horizons and renewed hope for patients and clinicians alike. Targeted therapies represent a class of treatments designed to selectively target specific molecular abnormalities or pathways essential for tumor growth and survival. By honing in on these unique molecular targets, targeted therapies aim to achieve higher efficacy with reduced systemic toxicity compared to conventional chemotherapy.